Osteoporosis: management and densitometry for orthopaedic surgeons.

Laura M B Gehrig, Cory Collinge, John Kaufman, Joseph M. Lane, Mary I. O'Connor, Laura L. Tosi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Osteoporosis is a metabolic condition that is increasing in prevalence as people live longer. A fracture is a sentinel event. Despite all the advances in technology, a history of low-energy fracture in adulthood is the best predictor of future fracture-an even better predictor than low bone mineral density. Osteoporosis and the risk of fracture go hand in hand. The orthopaedic surgeon is often viewed as an expert in managing and treating bone disorders. Given that the orthopaedic surgeon is often the first and only physician to evaluate a patient with a fracture, he or she may be in the ideal position to initiate patient evaluation and therapy. However, many times the orthopaedic surgeon is concerned about the adverse effects of the pharmacologic treatment of osteoporosis to the extent that prescribing these drugs is avoided. A treatment approach incorporating nonpharmacologic agents is an effective strategy in the prevention and treatment of osteoporosis.

Original languageEnglish (US)
Pages (from-to)805-815
Number of pages11
JournalInstructional course lectures
Volume58
StatePublished - 2009
Externally publishedYes

Fingerprint

Densitometry
Osteoporosis
Drug Prescriptions
Therapeutics
Bone Density
Technology
Physicians
Bone and Bones
Orthopedic Surgeons

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gehrig, L. M. B., Collinge, C., Kaufman, J., Lane, J. M., O'Connor, M. I., & Tosi, L. L. (2009). Osteoporosis: management and densitometry for orthopaedic surgeons. Instructional course lectures, 58, 805-815.

Osteoporosis : management and densitometry for orthopaedic surgeons. / Gehrig, Laura M B; Collinge, Cory; Kaufman, John; Lane, Joseph M.; O'Connor, Mary I.; Tosi, Laura L.

In: Instructional course lectures, Vol. 58, 2009, p. 805-815.

Research output: Contribution to journalArticle

Gehrig, LMB, Collinge, C, Kaufman, J, Lane, JM, O'Connor, MI & Tosi, LL 2009, 'Osteoporosis: management and densitometry for orthopaedic surgeons.', Instructional course lectures, vol. 58, pp. 805-815.
Gehrig LMB, Collinge C, Kaufman J, Lane JM, O'Connor MI, Tosi LL. Osteoporosis: management and densitometry for orthopaedic surgeons. Instructional course lectures. 2009;58:805-815.
Gehrig, Laura M B ; Collinge, Cory ; Kaufman, John ; Lane, Joseph M. ; O'Connor, Mary I. ; Tosi, Laura L. / Osteoporosis : management and densitometry for orthopaedic surgeons. In: Instructional course lectures. 2009 ; Vol. 58. pp. 805-815.
@article{a60d8be17c064591830bc0dc2802c3f0,
title = "Osteoporosis: management and densitometry for orthopaedic surgeons.",
abstract = "Osteoporosis is a metabolic condition that is increasing in prevalence as people live longer. A fracture is a sentinel event. Despite all the advances in technology, a history of low-energy fracture in adulthood is the best predictor of future fracture-an even better predictor than low bone mineral density. Osteoporosis and the risk of fracture go hand in hand. The orthopaedic surgeon is often viewed as an expert in managing and treating bone disorders. Given that the orthopaedic surgeon is often the first and only physician to evaluate a patient with a fracture, he or she may be in the ideal position to initiate patient evaluation and therapy. However, many times the orthopaedic surgeon is concerned about the adverse effects of the pharmacologic treatment of osteoporosis to the extent that prescribing these drugs is avoided. A treatment approach incorporating nonpharmacologic agents is an effective strategy in the prevention and treatment of osteoporosis.",
author = "Gehrig, {Laura M B} and Cory Collinge and John Kaufman and Lane, {Joseph M.} and O'Connor, {Mary I.} and Tosi, {Laura L.}",
year = "2009",
language = "English (US)",
volume = "58",
pages = "805--815",
journal = "Instructional course lectures",
issn = "0065-6895",
publisher = "American Association of Orthopaedic Surgeons",

}

TY - JOUR

T1 - Osteoporosis

T2 - management and densitometry for orthopaedic surgeons.

AU - Gehrig, Laura M B

AU - Collinge, Cory

AU - Kaufman, John

AU - Lane, Joseph M.

AU - O'Connor, Mary I.

AU - Tosi, Laura L.

PY - 2009

Y1 - 2009

N2 - Osteoporosis is a metabolic condition that is increasing in prevalence as people live longer. A fracture is a sentinel event. Despite all the advances in technology, a history of low-energy fracture in adulthood is the best predictor of future fracture-an even better predictor than low bone mineral density. Osteoporosis and the risk of fracture go hand in hand. The orthopaedic surgeon is often viewed as an expert in managing and treating bone disorders. Given that the orthopaedic surgeon is often the first and only physician to evaluate a patient with a fracture, he or she may be in the ideal position to initiate patient evaluation and therapy. However, many times the orthopaedic surgeon is concerned about the adverse effects of the pharmacologic treatment of osteoporosis to the extent that prescribing these drugs is avoided. A treatment approach incorporating nonpharmacologic agents is an effective strategy in the prevention and treatment of osteoporosis.

AB - Osteoporosis is a metabolic condition that is increasing in prevalence as people live longer. A fracture is a sentinel event. Despite all the advances in technology, a history of low-energy fracture in adulthood is the best predictor of future fracture-an even better predictor than low bone mineral density. Osteoporosis and the risk of fracture go hand in hand. The orthopaedic surgeon is often viewed as an expert in managing and treating bone disorders. Given that the orthopaedic surgeon is often the first and only physician to evaluate a patient with a fracture, he or she may be in the ideal position to initiate patient evaluation and therapy. However, many times the orthopaedic surgeon is concerned about the adverse effects of the pharmacologic treatment of osteoporosis to the extent that prescribing these drugs is avoided. A treatment approach incorporating nonpharmacologic agents is an effective strategy in the prevention and treatment of osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=67649185255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649185255&partnerID=8YFLogxK

M3 - Article

C2 - 19385588

AN - SCOPUS:67649185255

VL - 58

SP - 805

EP - 815

JO - Instructional course lectures

JF - Instructional course lectures

SN - 0065-6895

ER -